Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis *

The Six Area, Six Sign Atopic Dermatitis severity score has proved to be a simple and effective system for recording and monitoring disease activity in atopic dermatitis. The score is obtained by grading six signs (erythema, exudation, excoriation, dryness, cracking and lichenification), each on a scale of 0 (absent), 1 (mild), 2 (moderate), or 3 (severe), at each of six sites; arms, hands, legs, feet, head and neck, trunk. The maximum score is 108.

[1]  A. Finlay,et al.  Cyclosporine in severe childhood atopic dermatitis: a multicenter study. , 1996, Journal of the American Academy of Dermatology.

[2]  I. Strickland,et al.  Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis , 1996, The Lancet.

[3]  M. Sinisalo,et al.  Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy , 1995, The British journal of dermatology.

[4]  P. Hutchinson,et al.  Novel cycle changes in scalp hair are caused by etretinate therapy , 1995, The British journal of dermatology.

[5]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[6]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[7]  J. Berth-Jones,et al.  Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis , 1993, The Lancet.

[8]  R. MacKie,et al.  Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy , 1988, The British journal of dermatology.

[9]  D. Atherton,et al.  A controlled trial of traditional Chinese medicinal plants in widespread non‐exudative atopic eczema , 1992, The British journal of dermatology.

[10]  A. Y. Finlay,et al.  Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis , 1991, The Lancet.

[11]  D. Luscombe,et al.  Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double‐blind, placebo‐controlled trial , 1993, The British journal of dermatology.

[12]  J. Berth-Jones,et al.  Failure of papaverine to reduce pruritus in atopic dermatitis: a double‐blind, placebo‐controlled cross‐over study , 1990, The British journal of dermatology.